Coherus BioSciences, Inc. (CHRS) Operating Lease, Right-of-Use Asset USD 2018 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Coherus BioSciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2018 to 2023.
  • Coherus BioSciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $5.91 M, a 3.9% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $5.91 M +$222 K +3.9% Dec 31, 2023 10-K 2024-03-15
Q4 2022 $5.69 M -$2.5 M -30.6% Dec 31, 2022 10-K 2024-03-15
Q4 2021 $8.19 M -$1.76 M -17.7% Dec 31, 2021 10-K 2023-03-06
Q2 2021 $8.9 M -$2.1 M -19.1% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $9.43 M -$2.1 M -18.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $9.96 M -$693 K -6.51% Dec 31, 2020 10-K 2022-02-23
Q3 2020 $10.5 M -$663 K -5.96% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $11 M +$4.65 M +73.1% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $11.5 M +$4.76 M +70.4% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $10.6 M +$10.6 M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $11.1 M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $6.35 M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $6.77 M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.